Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
beta-Lactamases | 15 | 2023 | 306 | 2.390 |
Why?
|
Azabicyclo Compounds | 10 | 2022 | 68 | 2.390 |
Why?
|
Ceftazidime | 12 | 2019 | 69 | 2.170 |
Why?
|
Escherichia coli | 8 | 2016 | 4217 | 0.930 |
Why?
|
Microbial Sensitivity Tests | 15 | 2023 | 1877 | 0.660 |
Why?
|
Anti-Bacterial Agents | 14 | 2023 | 7181 | 0.640 |
Why?
|
Amino Acid Substitution | 5 | 2017 | 1791 | 0.530 |
Why?
|
Suppression, Genetic | 1 | 2015 | 196 | 0.520 |
Why?
|
Pseudomonas aeruginosa | 3 | 2022 | 1219 | 0.520 |
Why?
|
Clavulanic Acid | 1 | 2013 | 19 | 0.460 |
Why?
|
Drug Resistance, Bacterial | 3 | 2015 | 1035 | 0.450 |
Why?
|
Mutant Proteins | 1 | 2015 | 500 | 0.440 |
Why?
|
Multigene Family | 1 | 2015 | 1102 | 0.420 |
Why?
|
Sulfhydryl Compounds | 1 | 2013 | 298 | 0.400 |
Why?
|
beta-Lactam Resistance | 5 | 2017 | 79 | 0.340 |
Why?
|
Fosfomycin | 2 | 2019 | 25 | 0.300 |
Why?
|
Drug Combinations | 6 | 2022 | 1959 | 0.290 |
Why?
|
Pseudomonas Infections | 2 | 2022 | 613 | 0.280 |
Why?
|
Klebsiella pneumoniae | 3 | 2017 | 251 | 0.280 |
Why?
|
Ampicillin | 2 | 2015 | 139 | 0.250 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2019 | 567 | 0.240 |
Why?
|
Models, Molecular | 6 | 2015 | 5456 | 0.220 |
Why?
|
Ceftriaxone | 1 | 2023 | 168 | 0.210 |
Why?
|
Erysipelothrix | 1 | 2021 | 4 | 0.210 |
Why?
|
Kinetics | 6 | 2017 | 6473 | 0.210 |
Why?
|
Erysipelothrix Infections | 1 | 2021 | 5 | 0.210 |
Why?
|
Hand Dermatoses | 1 | 2021 | 61 | 0.200 |
Why?
|
Boronic Acids | 2 | 2016 | 965 | 0.180 |
Why?
|
Molecular Dynamics Simulation | 4 | 2017 | 413 | 0.180 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.170 |
Why?
|
Fingers | 1 | 2021 | 513 | 0.160 |
Why?
|
Acylation | 2 | 2015 | 107 | 0.160 |
Why?
|
Catalytic Domain | 3 | 2015 | 698 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Burkholderia cepacia complex | 1 | 2017 | 25 | 0.150 |
Why?
|
Crystallography, X-Ray | 4 | 2015 | 2011 | 0.150 |
Why?
|
Burkholderia Infections | 1 | 2017 | 44 | 0.140 |
Why?
|
Burkholderia pseudomallei | 1 | 2015 | 9 | 0.140 |
Why?
|
Circular Dichroism | 2 | 2013 | 354 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.130 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2013 | 276 | 0.120 |
Why?
|
Infection Control | 1 | 2022 | 966 | 0.120 |
Why?
|
Heterocyclic Compounds, 2-Ring | 1 | 2014 | 22 | 0.120 |
Why?
|
Bacterial Proteins | 3 | 2017 | 3848 | 0.120 |
Why?
|
Thiazolidines | 1 | 2014 | 74 | 0.120 |
Why?
|
Penicillanic Acid | 1 | 2014 | 45 | 0.120 |
Why?
|
beta-Lactams | 1 | 2015 | 160 | 0.110 |
Why?
|
Gram-Negative Bacteria | 1 | 2014 | 270 | 0.110 |
Why?
|
Protein Conformation | 3 | 2015 | 4011 | 0.110 |
Why?
|
Protein Structure, Secondary | 2 | 2013 | 1246 | 0.110 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
Protons | 1 | 2017 | 1127 | 0.100 |
Why?
|
Sulfones | 1 | 2014 | 437 | 0.100 |
Why?
|
Sequence Alignment | 1 | 2015 | 2256 | 0.100 |
Why?
|
Triazoles | 1 | 2016 | 911 | 0.090 |
Why?
|
Sepsis | 1 | 2023 | 2593 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
Mutagenesis | 1 | 2013 | 1266 | 0.080 |
Why?
|
Cephalosporins | 2 | 2023 | 204 | 0.080 |
Why?
|
Drug Synergism | 3 | 2019 | 1792 | 0.080 |
Why?
|
Drug Design | 1 | 2013 | 1076 | 0.070 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1940 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2015 | 13815 | 0.070 |
Why?
|
Hydrogen Bonding | 2 | 2017 | 293 | 0.070 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 18111 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.060 |
Why?
|
Imipenem | 1 | 2022 | 38 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6489 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Porins | 1 | 2022 | 81 | 0.050 |
Why?
|
Erythema | 1 | 2021 | 257 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2016 | 3129 | 0.040 |
Why?
|
Protein Binding | 3 | 2017 | 9386 | 0.040 |
Why?
|
Humans | 12 | 2023 | 744343 | 0.040 |
Why?
|
Mutation | 3 | 2019 | 29786 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2017 | 2203 | 0.040 |
Why?
|
Asparagine | 1 | 2017 | 122 | 0.040 |
Why?
|
Moths | 1 | 2017 | 87 | 0.040 |
Why?
|
Klebsiella Infections | 1 | 2017 | 138 | 0.040 |
Why?
|
Cephalothin | 1 | 2016 | 36 | 0.040 |
Why?
|
Amino Acids | 1 | 2022 | 1736 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
Aztreonam | 1 | 2015 | 12 | 0.030 |
Why?
|
Larva | 1 | 2017 | 519 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1616 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2017 | 389 | 0.030 |
Why?
|
Protein Engineering | 1 | 2017 | 540 | 0.030 |
Why?
|
Penicillins | 1 | 2016 | 380 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2015 | 1723 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.030 |
Why?
|
Hydrolysis | 1 | 2012 | 682 | 0.020 |
Why?
|
Models, Chemical | 1 | 2012 | 626 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1177 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2021 | 4042 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4986 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12959 | 0.020 |
Why?
|
Stem Cells | 1 | 2019 | 3567 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
Gene Expression | 1 | 2014 | 7799 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|
Male | 3 | 2021 | 350118 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Animals | 2 | 2019 | 168757 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 213383 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
United States | 1 | 2022 | 69872 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 72290 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81183 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
Female | 2 | 2019 | 380194 | 0.010 |
Why?
|
Aged | 1 | 2019 | 163280 | 0.000 |
Why?
|
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(92)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_